View Author
cancer tumor expression patient tumour treatment macrophage response mesothelioma immunotherapy pemetrexed t cells tacrolimu study nsclc tumour-bearing mice figure group effect celecoxib culture survival myeloid dendritic level number production journal myeloid cells tumour-bearing dc-based immunotherapy spleen vaccination coliti signi cox -2 expression differentiation concentration antigen disease release inhibition model splenocyte il -2 production m 2 macrophages control blood antibody ros production immunol effusion fluid marker gene expression injection administration reduction signature celecoxib diet lysate percentage il -2 release t-cell dendritic cells cd 206 zoledronic condition staining suppression tumour injection population tumour progression netherland mo-mdsc increase therapy function flammatory murine cox -2
7 Most Recent Publications
|
Expression profiling-based subtyping identifies novel non-small cell lung cancer subgroups and implicates putative resistance to pemetrexed therapy
(Article)
Hou, J. Lambers, M.E.H. Den Hamer, B. Bakker, M.A. den Hoogsteden, H.C. Grosveld, F.G. Hegmans, J.P. Aerts, J.G.J.V. Philipsen, S. |
2012-01-01
|
|
Anti-inflammatory actions of phosphatidylinositol
(Article)
Dieren, J.M. van Simons-Oosterhuis, Y. Lambrecht, B.N.M. Samsom, J.N. Nieuwenhuis, E.E.S. Raatgeep, H.C.R. Lindenbergh-Kortleve, D.J. Lambers, M.E.H. Woude, C.J. van der Kuipers, E.J. Snoek, G.T. Potman, R. Hammad, H. |
2011-04-01
|
|
Local immune regulation of mucosal inflammation by tacrolimus
(Article)
Dieren, J.M. van Lambers, M.E.H. Kuipers, E.J. Samsom, J.N. Woude, C.J. van der Nieuwenhuis, E.E.S. |
2010-09-01
|
|
COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
(Article)
Veltman, J.D. Lambers, M.E.H. Nimwegen, M. van Hendriks, R.W. Hoogsteden, H.C. Aerts, J.G.J.V. Hegmans, J.P. |
2010-08-30
|
|
Zoledronic acid impairs myeloid differentiation to tumour-associated macrophages in mesothelioma
(Article)
Veltman, J.D. Lambers, M.E.H. Nimwegen, M. van Hendriks, R.W. Hoogsteden, H.C. Hegmans, J.P. Aerts, J.G.J.V. |
2010-08-01
|
|
Low-dose cyclophosphamide synergizes with dendritic cell-based immunotherapy in antitumor activitys
(Article)
Veltman, J.D. Lambers, M.E.H. Nimwegen, M. van Jong, S. de Hendriks, R.W. Hoogsteden, H.C. Aerts, J.G.J.V. Hegmans, J.P. |
2010-06-18
|
|
Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma
(Article)
Hegmans, J.P. Veltman, J.D. Lambers, M.E.H. Vries, I.J.M. de Figdor, C.G. Hendriks, R.W. Hoogsteden, H.C. Lambrecht, B.N.M. Aerts, J.G.J.V. |
2010-06-15
|
